Page last updated: 2024-12-05
3-phenoxy-1,2-propanediol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
3-phenoxy-1,2-propanediol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10857 |
SCHEMBL ID | 117951 |
MeSH ID | M0517024 |
Synonyms (68)
Synonym |
---|
1,2-propanediol,3-phenoxy- |
1-fenoxy-2,3-propandiol |
38d39w41ij , |
unii-38d39w41ij |
3-phenoxy-propane-1,2-diol |
1,2-propanediol, 3-phenoxy- |
3-phenoxypropane-1,2-diol |
3-phenoxy-1,2-propanediol |
538-43-2 |
phenol-glycerinaether [german] |
phenyl-alpha-glycerol ether |
1-fenoxy-2,3-propandiol [czech] |
glycerol alpha-phenyl ether |
glycerol alpha-monophenyl ether |
nsc 406489 |
alpha-phenyl monoglyceryl ether |
einecs 208-692-8 |
antodyn |
u 27,462 |
1-phenoxy-2,3-propanediol |
brn 1869155 |
phenol glycerol ether |
glycerol .alpha.-phenyl ether |
glycerol .alpha.-monophenyl ether |
phenylglyceryl ether |
1, 3-phenoxy- |
phenyl-.alpha.-glycerol ether |
nsc406489 |
phenol-glycerinaether |
wln: q1yq1or |
phenol glyceryl ether |
antodyne |
nsc-406489 |
FT-0653722 |
3-(phenoxy)propane-1,2-diol |
inchi=1/c9h12o3/c10-6-8(11)7-12-9-4-2-1-3-5-9/h1-5,8,10-11h,6-7h2 |
fnqiytuxoktmdm-uhfffaoysa- |
P1335 |
STK801832 |
einecs 240-413-5 |
A829794 |
phenyl glyceryl ether |
3-(phenyloxy)-2-hydroxypropylagarose |
3-popa |
92768-70-2 |
AKOS015889994 |
3-phenoxy-1,2-propandiol |
SCHEMBL117951 |
phenoxypropanediol [inci] |
phenylglyceryl ether [mi] |
1-phenoxymethyl-1,2-ethanediol |
phenoxypropanediol |
phenoxy propanediol 816430 |
phenoxypropanediol, (+/-)- |
(+/-)-phenoxypropanediol |
.alpha.-phenyl monoglyceryl ether |
1,2-dihydroxy-3-phenoxypropane |
W-105702 |
mfcd00004717 |
FT-0772119 |
AS-17522 |
Q21547178 |
DTXSID90870597 |
AMY25081 |
phenylglycerol |
D92114 |
SB47006 |
EN300-266570 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.50) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |